Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Blanke

Showing results (111-120 of 190) with videos related to

Pageof 19
Sort By:
Molecular Cancer Therapeutics|August 13, 2009
Gene expression signatures and response to imatinib mesylate in gastrointestinal stromal tumorLori Rink, Yuliya Skorobogatko, Andrew V Kossenkov, et al.
Oncology Reports|June 6, 2007
Epithelioid gastric stromal tumours of the antrum in young females with the Carney triad: a report of three new cases with mutational analysis and comparative genomic hybridizationAbbas Agaimy, Antje-Friederike Pelz, Christopher L Corless, et al.
Annals of Surgical Oncology|December 29, 2011
Phase II trial of neoadjuvant/adjuvant imatinib mesylate for advanced primary and metastatic/recurrent operable gastrointestinal stromal tumors: long-term follow-up results of Radiation Therapy Oncology Group 0132Dian Wang, Qiang Zhang, Charles D Blanke, et al.
American Journal of Surgery|June 12, 1999
Transcatheter arterial chemoembolization as primary treatment for hepatocellular carcinomaD M Rose, W C Chapman, A T Brockenbrough, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 4, 2022
Sex Differences in Risk of Severe Adverse Events in Patients Receiving Immunotherapy, Targeted Therapy, or Chemotherapy in Cancer Clinical TrialsJoseph M Unger, Riha Vaidya, Kathy S Albain, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2006
Phase II trial of erlotinib in gastroesophageal junction and gastric adenocarcinomas: SWOG 0127Tomislav Dragovich, Sheryl McCoy, Cecilia M Fenoglio-Preiser, et al.
American Journal of Clinical Oncology|May 22, 2018
A Phase II Study of Celecoxib With Irinotecan, 5-Fluorouracil, and Leucovorin in Patients With Previously Untreated Advanced or Metastatic Colorectal CancerEmerson Y Chen, Charles D Blanke, Daniel G Haller, et al.
Annals of Surgical Oncology|January 9, 2023
Adjuvant Chemoradiation in Patients with Lymph Node-Positive Biliary Tract Cancers: Secondary Analysis of a Single-Arm Clinical Trial (SWOG 0809)Sepideh Gholami, Sarah Colby, David P Horowitz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 7, 2005
Impact of the year 2000 Medicare policy change on older patient enrollment to cancer clinical trialsJoseph M Unger, Charles A Coltman, John J Crowley, et al.
Clinical Colorectal Cancer|July 26, 2011
Colorectal Chemoprevention Pilot Study (SWOG-9041), randomized and placebo controlled: the importance of multiple luminal lesionsDavid Z J Chu, Michael A Hussey, David S Alberts, et al.
Pageof 19

Showing results (111-120 of 190) with videos related to

Sort By:
Pageof 19
Molecular Cancer Therapeutics|August 13, 2009
Gene expression signatures and response to imatinib mesylate in gastrointestinal stromal tumorLori Rink, Yuliya Skorobogatko, Andrew V Kossenkov, et al.
Oncology Reports|June 6, 2007
Epithelioid gastric stromal tumours of the antrum in young females with the Carney triad: a report of three new cases with mutational analysis and comparative genomic hybridizationAbbas Agaimy, Antje-Friederike Pelz, Christopher L Corless, et al.
Annals of Surgical Oncology|December 29, 2011
Phase II trial of neoadjuvant/adjuvant imatinib mesylate for advanced primary and metastatic/recurrent operable gastrointestinal stromal tumors: long-term follow-up results of Radiation Therapy Oncology Group 0132Dian Wang, Qiang Zhang, Charles D Blanke, et al.
American Journal of Surgery|June 12, 1999
Transcatheter arterial chemoembolization as primary treatment for hepatocellular carcinomaD M Rose, W C Chapman, A T Brockenbrough, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 4, 2022
Sex Differences in Risk of Severe Adverse Events in Patients Receiving Immunotherapy, Targeted Therapy, or Chemotherapy in Cancer Clinical TrialsJoseph M Unger, Riha Vaidya, Kathy S Albain, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2006
Phase II trial of erlotinib in gastroesophageal junction and gastric adenocarcinomas: SWOG 0127Tomislav Dragovich, Sheryl McCoy, Cecilia M Fenoglio-Preiser, et al.
American Journal of Clinical Oncology|May 22, 2018
A Phase II Study of Celecoxib With Irinotecan, 5-Fluorouracil, and Leucovorin in Patients With Previously Untreated Advanced or Metastatic Colorectal CancerEmerson Y Chen, Charles D Blanke, Daniel G Haller, et al.
Annals of Surgical Oncology|January 9, 2023
Adjuvant Chemoradiation in Patients with Lymph Node-Positive Biliary Tract Cancers: Secondary Analysis of a Single-Arm Clinical Trial (SWOG 0809)Sepideh Gholami, Sarah Colby, David P Horowitz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 7, 2005
Impact of the year 2000 Medicare policy change on older patient enrollment to cancer clinical trialsJoseph M Unger, Charles A Coltman, John J Crowley, et al.
Clinical Colorectal Cancer|July 26, 2011
Colorectal Chemoprevention Pilot Study (SWOG-9041), randomized and placebo controlled: the importance of multiple luminal lesionsDavid Z J Chu, Michael A Hussey, David S Alberts, et al.
Pageof 19